Isolated Naratriptan-Associated Ischemic Colitis

Autor:	George Nissan, Steven Mudrovich, Priyanka Chaudhry, Asra Akbar, Priya Rangasamy
Rok vydání:	2016
Předmět:	Cardiovascular History Naratriptan Side effect business.industry General Medicine Triptans medicine.disease Ischemic colitis Discontinuation Case Studies Migraine Anesthesia medicine Headaches medicine.symptom business medicine.drug
Zdroj:	Baylor University Medical Center Proceedings. 29:410-411
ISSN:	1525-3252 0899-8280
Popis:	We report a 41-year-old woman who developed histology- and colonoscopy-proven ischemic colitis with the use of naratriptan not exceeding the maximum 2 doses a day and 3 days per week and without a known medical or cardiovascular history. By exclusion of other causes of colonic ischemia, naratriptan was considered the sole causal agent. Discontinuation of naratriptan resulted in a complete clinical recovery. To date, our patient is the youngest known patient to develop ischemic colitis on isolated naratriptan in the setting of no known medical risk factors or predisposing medical condition. Even though triptans are commonly used for the abortive treatment of migraine headaches, such a reported side effect is rare; however, careful assessment and individual patient-based treatment is advised.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c63c27991e259bd4d7257ce561903cf https://doi.org/10.1080/08998280.2016.11929490 Zobrazit plný text záznamu